Tony Windsor (New England, Independent) Share this | Hansard source

My question is to the Minister for Health. Minister, given the government's priorities in relation to the NDIS and education reform, does the minister believe that there is scope for savings in the Pharmaceutical Benefits Scheme through the extension of the supply of generic drugs under the PBS to fund those reforms?

See this speech in context